Utjecaj pandemije COVID-19 na skrining kolorektalnog karcinoma: sistematski pregled.
Journal of gastrointestinal cancer
Sažetak istraživanja
Pozadina Nakon što je Svjetska zdravstvena organizacija (WHO) objavila globalnu pandemiju COVID-19 u martu 2020. i premještanje zdravstvenih resursa za kontrolu ove infekcije, programi skrininga raka, posebno kolorektalnog karcinoma (CRC) su obustavljeni u mnogim zemljama. Prema podacima GLOBOCAN 2020, CRC je treći po učestalosti i drugi najsmrtonosniji rak na svijetu. Dakle, rano otkrivanje kroz skrining je od suštinskog značaja za smanjenje smrtnosti povezane s ovim rakom. Ova studija je osmišljena da istraži uticaj pandemije COVID-19 na skrining kolorektalnog karcinoma.
Metode i materijali Opsežna pretraga obavljena juna 2021. u različitim bazama podataka, uključujući Medline, Web of Science i Scopus. Ključne riječi kao što su "Rano otkrivanje", "Rak", "Skrining raka", "Testovi za skrining raka", "Koronavirusna bolest-19", "COVID 19", "Bolest korona virusom", "Infekcija SARS-CoV-2", "SARS-CoV-9," "CoV10" "2012" Za pretraživanje pojedinačno ili u kombinaciji korišteni su roman", "SARS COV 2 Virus", "Teški akutni respiratorni sindrom Koronavirus 2", "COVID-19", "COVID-19, Coronavirus Disease 19", "SARS Coronavirus 2", "Kolorektalna neoplazma" i "Kancer kolorektuma". Svi članci su uneseni u Endnote X7 softver koji uklanja duplikate. Zatim su studije prvo odabrane po naslovu, a zatim po sažetku i na kraju su istraženi puni tekstovi.
Rezultati Od 850 identifikovanih studija, 25 je identifikovano kao kvalifikovano.
Rezultati studija pokazuju da se općenito skrining raka debelog crijeva smanjio sa 28 na 100% u različitim zemljama iu različito vrijeme nakon početka pandemije COVID-19. Tokom ovog perioda, samo 2 do 2,5% bolnica i skrining centara sa 100% kapaciteta nastavilo je sa radom, a više od 77% njih ograničilo je svoje aktivnosti na manje od 10% svog normalnog kapaciteta. Takođe, završetak kolonoskopija za koje je potreban pregled pokazao je pad od 65,7%, nadzorna kolonoskopija je pokazala smanjenje od 44,6 do 79%, kolonoskopija na receptu je smanjena za 60 do 81%, a upućivanje na kolonoskopiju je pokazalo pad od 43%. Međutim, hitna kolonoskopija pokazuje povećanje od 2 do 9%. Upotreba fekalnog imunohemijskog testa (FIT) također općenito opada, ali se povećava u područjima koja se koriste kao alternativa kolonoskopiji.
Zaključci S obzirom na to da je smanjenje skrininga na rak debelog crijeva nakon pandemije COVID-19 posljedica ograničenja nametnutih zbog visoke prevalencije bolesti COVID-19 i nedostatka uputnica zbog straha od razvoja infekcije COVID-19; Nadoknađivanje pada i sprečavanje nastavka ovog opadajućeg trenda zahtijeva ozbiljne i efikasne intervencije kako bi se održali kapaciteti službi za skrining tokom COVID-19 krize, povećali kapaciteti skrining centara za vrijeme ukidanja ograničenja i smanjio strah u javnosti.
Prikaži originalni naslov i sažetak na engleskom
Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Background After the World Health Organization (WHO) announcing about global pandemic of COVID-19 in March 2020 and relocation of health care resources for controlling this infection, cancer screening programs especially colorectal cancer (CRC) have been suspended in many countries. According to GLOBOCAN 2020 data, CRC is the third prevalent and second deadliest cancer in the world. So, early detection through screening is essential to reduce the mortality associated with this cancer. The present study was designed to investigate the impact of COVID-19 pandemic on colorectal cancer screening.
Methods and materials A comprehensive search performed on June 2021 in various databases, including Medline, Web of Science, and Scopus. Keywords such as "Early Detection," "Cancer," "Cancer Screening," "Cancer Screening Tests," "Coronavirus Disease-19," "COVID 19," "Coronavirus Disease," "SARS-CoV-2 Infection," "SARS-CoV-2," "2019-nCoV," "coronavirus, 2019 Novel," "SARS COV 2 Virus," "Severe Acute Respiratory Syndrome Coronavirus 2," "COVID-19," "COVID-19, Coronavirus Disease 19," "SARS Coronavirus 2","Colorectal neoplasm" and "Colorectal Cancer" were used individually or in combination to search. All articles were entered into Endnote X7 software that remove duplicates. Then, studies were first selected by title and then by abstract and at the end full texts were investigated.
Results Of the 850 identified studies, 25 were identified as eligible. The results of studies show that in general, colorectal cancer screening has decreased from 28 to 100% in different countries and at different times after the onset of the COVID-19 pandemic. During this period, only 2 to 2.5% of hospitals and screening centers with 100% capacity continued to operate, and more than 77% of them limited their activities to less than 10% of their normal capacity. Also, completion of colonoscopies requiring examination showed a decrease of 65.7%, surveillance colonoscopy showed a decrease of 44.6 to 79%, prescription colonoscopy decreased 60 to 81%, and referrals to colonoscopy showed a 43% decline. However, emergency colonoscopy shows a 2 to 9% increase. The use of the Fecal immunochemical test (FIT) test is also generally declining but is increasing in areas used as a colonoscopy alternative.
Conclusions Considering that the reduction in colorectal cancer screening following COVID-19 pandemic is due to the restrictions imposed for the high prevalence of COVID-19 disease and the lack of referrals due to the fear of developing COVID-19 infection; compensating for the decline and preventing the continuation of this decreasing trend requires serious and effective interventions to maintain the capacity of screening services during the COVID-19 crisis, increase the capacity of screening centers during the lifting of restrictions and reduce fear in the public.
Izvorni podaci
- DOI
- 10.1007/s12029-021-00679-x
- PMID
- 34406626
- PMCID
- PMC8371036
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom